glp-1 muscle pain Joint, Muscle, & Nerves Daily Green Packs for Relief Muscle Loss with GLP-1 Medications:

Vitamin D supplementation in obesity and during weight loss: a review of randomized controlled trials

The trial found that after 5 years, Wegovy significantly reduced the risk of death from heart disease by 15% and reduced the risk of cardiovascular events including nonfatal heart attacks and strokes by 20%, compared to an inactive placebo

For people still on injectables, resources such as a stepbystep guide on injecting retatrutide can help make selfinjection feel more manageable

PMID: 25659981

The India Anti-Obesity Drug Market is estimated to be valued at USD 1.24 Bn in 2026 and is expected to reach USD 4.38 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 19.7% from 2026 to 2032